Related Experiment Video
Updated: Jun 5, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Molecular genetics in IgA nephropathy
1Division of Nephrology and Hypertension, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. john.galla@uc.edu
Genetic factors may predispose individuals to IgA nephropathy (IgAN) and Henoch-Schönlein purpura (HSP). Understanding the genetic mechanisms of progressive renal failure in these conditions is crucial.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- IgA nephropathy (IgAN) and Henoch-Schönlein purpura (HSP) are kidney diseases with unclear genetic links.
- These conditions are notably uncommon in Black populations, a phenomenon yet to be explained.
- Existing research has not consistently linked specific genotypes or HLA antigens to disease development or progression.
Purpose of the Study:
- To explore potential genetic predispositions to IgAN and HSP.
- To investigate factors contributing to the progression of these diseases to chronic renal failure.
- To examine the role of IgA immunobiology and complement pathways in disease pathogenesis.
Main Methods:
- Review of genotypic and phenotypic evidence related to IgAN and HSP.
- Analysis of the association between IgA immunobiology, complement factor 3, and disease progression.
- Consideration of the potential role of angiotensin-related polymorphisms.
Main Results:
- No consistent genetic or HLA associations have been identified for IgAN or HSP.
- Complement factor 3 is universally present with IgA deposition, but pathway abnormalities are sporadic.
- The role of angiotensin-converting enzyme alleles in IgAN progression remains uncertain.
Conclusions:
- A potential structural defect in IgA1, stemming from an unidentified genetic defect, is a promising area of investigation for IgA deposition.
- The underlying genetic mechanisms driving progressive renal failure in IgAN and other glomerular diseases are of critical importance.
- Further research is needed to elucidate the genetic underpinnings of IgAN and HSP progression.
More Related Videos
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenomics: Identification of New Drug Targets
Diabetic Nephropathy

